Q1 2019 Holdings
Filed 2019-05-15 | 53 holdings | $98.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $35.1M | 2,810,223 | 35.8% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $30.8M | 3,801,817 | 31.4% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $12.9M | 1,198,000 | 13.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $10.1M | 80,868 | 10.3% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $8.5M | 2,109,342 | 8.6% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $83.4K | 3,420,562 | 0.1% |
| Merus N V | COM | N5749R100 | $67.1K | 4,539,913 | 0.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $45.2K | 564,965 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $41.4K | 2,495,156 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $41.1K | 3,064,346 | 0.0% |
| AC Immune SA(ACIU) | SHS | H00263105 | $37.7K | 7,455,534 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $32.8K | 17,426,968 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $31.6K | 431,700 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $30.2K | 6,308,746 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $24.5K | 1,606,817 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $21.9K | 1,769,029 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $20.8K | 3,579,140 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $20.5K | 1,400,956 | 0.0% |
| Calithera Biosciences Inc(CALAEUR) | COM | 13089P101 | $20.4K | 3,023,482 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $20.3K | 1,464,515 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $18.2K | 1,788,774 | 0.0% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $16.7K | 1,385,487 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $16.1K | 220,265 | 0.0% |
| Galmed Pharmaceuticals LTD(GLMD) | SHS | M47238106 | $15.3K | 1,878,508 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $14.1K | 1,123,255 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $13.6K | 4,058,385 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $13.2K | 2,500,000 | 0.0% |
| Biolinerx LTD | SPONSORED ADS | 09071M106 | $11.2K | 25,995,575 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $10.4K | 1,987,669 | 0.0% |
| Verastem Inc | COM | 92337C104 | $10.4K | 3,513,994 | 0.0% |
| Forward Pharma A/S | SPONSORED ADR | 34986J105 | $10.0K | 8,480,079 | 0.0% |
| Spring BK Pharmaceuticals Inc | COM | 849431101 | $10.0K | 951,701 | 0.0% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $9.4K | 675,000 | 0.0% |
| VBI Vaccines Inc(VAC2USD) | COM NEW | 91822J103 | $8.8K | 4,722,572 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $8.3K | 2,698,755 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $8.2K | 1,201,717 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM NEW | 12648L601 | $6.7K | 6,929,690 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $6.5K | 200,500 | 0.0% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $5.9K | 310,299 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $5.9K | 460,706 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $5.8K | 3,293,000 | 0.0% |
| Erytech Pharma | SPONSORED ADR | 29604W108 | $4.8K | 625,000 | 0.0% |
| Genocea Biosciences Inc | COM | 372427104 | $4.6K | 7,828,243 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $4.5K | 1,710,684 | 0.0% |
| Oncomed Pharmaceuticals Inc | COM | 68234X102 | $4.3K | 4,108,815 | 0.0% |
| Sunesis Pharmaceuticals Inc | COM PAR | 867328700 | $2.8K | 2,287,860 | 0.0% |
| Vical Inc | COM NEW | 925602203 | $2.7K | 2,279,059 | 0.0% |
| Realm Therapeutics PLC | SPONSORED ADS | 75606L103 | $2.4K | 612,889 | 0.0% |
| Surface Oncology Inc | COM | 86877M209 | $2.2K | 451,850 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $2.0K | 580,368 | 0.0% |